必博bibo

    语言版本选择
    R&D
    R&D CTTQ has established several R&D centers to develop innovative drugs, generics and biopharmaceuticals.

    R&D Institute

    CTTQ R & D Institute was founded in 1985 to develop innovative drugs, generics, and biopharmaceuticals. The annual R & D expenditure, which is 2.7 billion in 2021, is more than 12% of CTTQ's annual revenue. The institute ranks as one of the “Top 5 most innovative Pharmaceutical Enterprises in China”.

     

    Therapeutic Areas (% of Total Projects)

    • 0 Oncology
    • 0 Hepatitis
    • 0 Antibiotics
    • 0 Respiratory
    • 0 Cardiovascular
    • 0 OTHER

    • R&D Team

      CTTQ R & D Institute has more than 1800 employees, specializing in chemistry, biology, pharmacology, analysis, and medical science, etc. Over 60% of them hold Master or Doctoral degrees.

    • Patents

      By the end of 2021, we have filed 2294 patents, including 2185 inventions. Among them, 792 patents have been granted, including 688 inventions.
    友情链接: